Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Can Emergent BioSolutions Recover From Its Recent Blunders?

TheMotleyFool

0 0

Can Emergent BioSolutions Recover From Its Recent Blunders?

They say that any publicity is good publicity. Emergent BioSolutions (NYSE: EBS) might disagree after its highly publicized COVID-19 vaccine manufacturing problems. In this Motley Fool Live video recorded on June 23, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about whether or not Emergent BioSolutions can recover from its recent blunders.

Source Fool.com

Like: 0

EBS

Share